The key equity indices traded with moderate losses in mid-afternoon trade. Market participants will closely track crude oil prices, FII activity, and developments on the tariff front, while awaiting CPI data, scheduled for later today. The Nifty traded near 24,550 mark. Pharma shares advanced for the second consecutive trading session. At 14:25 IST, the barometer index, the S&P BSE Sensex declined 188.02 points or 0.23% to 80,420.40. The Nifty 50 index fell 37.50 points or 0.15% to 24,546.80. In the broader market, the S&P BSE Mid-Cap index shed 0.03% and the S&P BSE Small-Cap index rose 0.10%. The market breadth was negative. On the BSE, 2,131 shares rose and 1,865 shares fell. A total of 153 shares were unchanged. The Nifty Pharma index rose 0.96% to 21,811.35. The index rose 1.91% in the past two trading session. Alkem Laboratories (up 7.24%), Granules India (up 4.3%), Biocon (up 4.27%), Ipca Laboratories (up 4.26%) and Abbott India (up 2.08%) were the top gainers. Among the other gainers were Sun Pharmaceutical Industries (up 1.7%), Ajanta Pharma (up 1.54%), Aurobindo Pharma (up 1.41%), Glenmark Pharmaceuticals (up 1.12%) and Laurus Labs (up 1.02%) surged. The yield on India's 10-year benchmark federal paper rose 0.56% to 6.464 from the previous close of 6.428. In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 87.6300 compared with its close of 87.7500 during the previous trading session. MCX Gold futures for 3 October 2025 settlement fell 0.24% to Rs 100,080. The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.01% to 98.52. The United States 10-year bond yield shed 0.16% to 4.278. In the commodities market, Brent crude for October 2025 settlement declined 6 cents or 0.09% to $66.57 a barrel. Abbott India gained 1.96% after the company's standalone net profit climbed 11.53% to Rs 365.86 crore on 11.60% increase in revenue from operations to Rs 1,738.35 crore in Q1 FY26 over Q1 FY25. Kirloskar Industries declined 2.48% after the company reported a 1.73% decrease in consolidated net profit to Rs 95.48 crore in Q1 FY26 as against Rs 97.09 crore reported in Q4 FY25. Revenue from operations fell 2.42% quarter-on-quarter (QoQ) to Rs 1,705.48 crore in the quarter ended 30 June 2025. Praj Industries declined 7.29% after the company's consolidated net profit declined 93.7% to Rs 5.34 crore on 8.4% fall in net sales to Rs 640.20 crore in Q1 FY26 over Q1 FY25.

Sensex, Nifty trade lower; pharma shares climb for 2nd day

The S&P BSE Sensex and Nifty 50 indices declined slightly in mid-afternoon trading, with the Sensex falling 0.23% to 80,420.40 and the Nifty 50 dropping 0.15% to 24,546.80. Pharma shares advanced for the second consecutive session, with the Nifty Pharma index rising 0.96% to 21,811.35. Key pharma gainers included Alkem Laboratories, Granules India, Biocon, Ipca Laboratories, and Abbott India. Abbott India reported an 11.53% increase in standalone net profit to Rs 365.86 crore in Q1 FY26, driven by an 11.60% rise in revenue. Kirloskar Industries and Praj Industries reported declines in net profit, with Kirloskar's falling 1.73% and Praj's dropping 93.7% in Q1 FY26. The 10-year Indian government bond yield rose to 6.464%, while the rupee strengthened to 87.6300 against the dollar. Brent crude fell to $66.57 per barrel.